SB 220: "Putting Georgia's Patients First Act"; enact

In plain language

What the bill does

Who it affects

Why it matters

Key provisions

Discussed in meetings (8)

The House and Senate meetings that took this bill up, from their machine transcripts. Each account was written by Georgia Commons with AI and is not part of the record; the video is what was said.

1. House Regulated Industries Committee, February 9, 2026

   From 0:21:29 · Watch on the General Assembly's Vimeo channel

   Summary by Georgia Commons: The House sponsor presented a substitute to expand medical cannabis forms and qualifying conditions, ease dispensary location limits, provide electronic cards and strengthen oversight. The sponsor said it would replace percentage-based oil limits with limits of 1,200 milligrams per package and 12,000 milligrams in possession, allow vaporization for adults 21 and older, retain the smoking ban and require physicians’ principal practices to be in Georgia. Members questioned potency, repeat purchases, tracking and rural telehealth access. The sponsor emphasized milligram dosing, said purchases were electronically reported and said Georgia-based telehealth would remain allowed. A patient advocate opposed excluding out-of-state physicians. A patient with multiple sclerosis and a veteran described benefits; a physician supported broader forms and dosing flexibility and requested fewer paperwork barriers. Another witness warned about addiction and impairment, while a Georgia Baptist Mission Board witness cautioned against expansion toward recreational use. A member proposed deleting the public-use ban, arguing patients might need treatment during a crisis. The sponsor acknowledged its breadth but requested a narrower ban on public vaporization to protect bystanders. The deletion amendment failed by voice vote. The committee then approved substitute LC339865S by voice vote, with opposition heard and no count stated.

2. House Rules Committee, February 17, 2026

   From 0:50:20 · Watch on the General Assembly's Vimeo channel

   Summary by Georgia Commons: The Senate sponsor said the bill concerned the medical THC program and had become more restrictive than the version sent to the House. The sponsor said the priority was getting medicine to patients with one of 17 qualifying illnesses or diagnoses, but did not describe the restrictions in detail. No questions or decision followed.

3. House Rules Committee, March 11, 2026

   From 0:27:32 · Watch on the General Assembly's Vimeo channel · Confirmed by the 2026 House Journal, p. 2584

   Summary by Georgia Commons: After a motion and second, the committee placed SB 220 on the next day's House calendar with no stated opposition. No explanation of the bill's contents was given.

4. House floor session, March 12, 2026 (legislative day 31)

   From 1:39:07 · Watch on the General Assembly's Vimeo channel · Confirmed by the 2026 House Journal, p. 2610

   Summary by Georgia Commons: The presenter said the committee substitute for SB 220 followed four public meetings and testimony from more than 60 witnesses. The presenter described renaming low-THC oil as medical cannabis, measuring limits in milligrams, lowering package limits from 1,400 to 1,200 milligrams and possession limits from 28,000 to 12,000 milligrams, allowing inhalation for adults 21 and older, expanding qualifying conditions, enabling electronic cards, revising dispensary location rules and requiring certifying physicians to practice primarily in Georgia. The presenter said inhalation could provide faster relief while smoking and public use would remain prohibited. One member asked how patients could take medicine during an episode at church or a park. The presenter said patients would need a private place, citing public exposure concerns. A second member asked about inhalation safety; the presenter described measured doses. A third asked about nerve pain and lasting relief; the presenter said some patients benefit and could dose before outings. Five supporting speakers emphasized patient access: the majority leader discussed balancing science and policy; another member stressed pain relief; an attorney described families’ prosecution fears; another member recounted family and constituent hardships; and a veteran member emphasized PTSD and sickle cell disease. The House adopted the substitute and passed the bill, 138 to 21.

5. Senate floor session, March 16, 2026 (legislative day 32)

   From 4:00:31 · Watch on the General Assembly's Vimeo channel

   Summary by Georgia Commons: A senator gave notice of an intention to ask the Senate on the next legislative day to consider House action on SB 220. The clerk described provisions renaming low-THC oil as medical cannabis and revising criminal penalties. The Senate did not debate or vote on the House action during this session.

6. Senate floor session, March 18, 2026 (legislative day 33)

   From 5:57:54 · Watch on the General Assembly's Vimeo channel · Confirmed by the bill's status history (Senate Agreed House Amend or Sub As Amended)

   Summary by Georgia Commons: The sponsor sought agreement to House changes to SB 220, with further amendments. The sponsor described renaming low-THC oil as medical cannabis, permitting private vaporization of oils and plant material, replacing the 5% THC cap with milligram limits, expanding caregivers, easing card requirements, changing dispensary setbacks, and permitting limited informational advertising. In closing, the sponsor clarified that vaping would be limited to people aged 22 or older and possession to ten 1,200-milligram packages, totaling 12,000 milligrams. The sponsor proposed removing severe insomnia and severe arthritis from qualifying conditions, leaving additions guided by medical agencies. Another amendment made electronic cards subject to funding, citing an estimated $650,000 startup cost. Supporters cited pain relief, seizures, veterans' needs, regulated product safety, and alternatives to opioids. One physician member supported milligram dosing and Georgia-based physician practice requirements. Opponents argued that highly concentrated THC and vaping would move the program toward recreational use. They cited addiction, mental health, family, workplace, and enforcement concerns. The sponsor disputed the recreational-use characterization and said the possession limit would be lower than current law. The Senate adopted the electronic-card amendment 36-15 and agreed to the House substitute as amended 38-14.

7. House floor session, March 23, 2026 (legislative day 36, PM)

   From 0:33:13 · Watch on the General Assembly's Vimeo channel · Confirmed by the bill's status history (House Agreed Senate Amend or Sub)

   Summary by Georgia Commons: The presenter asked the House to accept Senate changes to SB 220, a medical cannabis measure. The presenter said the Senate retained lupus as a qualifying condition but removed severe arthritis and severe insomnia because new conditions were supposed to receive agency review first. The presenter said severe arthritis could still qualify under intractable pain and intended to seek review of both removed conditions. One member questioned why an established diagnosis such as rheumatoid arthritis needed further review. The presenter clarified that review concerned eligibility for cannabis treatment, not whether patients needed a new diagnosis. Another member questioned amendment line numbering, which the presenter said legislative counsel had approved. A supportive member highlighted expanded access and formulations. The presenter said the broader bill also changed dosing measurements and strengthened physician oversight. Asked about insomnia, the presenter described mixed evidence and supported further review. The presenter also said electronic registry cards would depend on appropriated funding at the Department of Public Health's request. After a delay to distribute amendment copies, the House agreed to the Senate amendment 144 to 21.

• Read aloud: House floor session, February 10, 2026 (legislative day 16), 0:49:54

Status timeline

Sponsors

Votes

Topics